Born in Munich, he first studied economics and graduated in business administration at the Ludwig-Maximilians-University in 1995. As he was involved with the stock market at a very early stage, he now has more than 30 years of experience in the capital markets. In the historic dot.com year 2000, he trained as a CEFA analyst in Frankfurt and has since then accompanied over 20 IPOs in Germany.
Until 2018, he held various positions at banks as an asset manager, capital market and macro expert as well as fundamental equity analyst. He is passionate about the energy, commodity and technology markets as well as the tactical and strategic asset allocation of liquid investment products. As an expert speaker at investment committee meetings of funds as well as at customer events, he can still describe the course of the 1987 crash, one of the major buying opportunities of the last 33 years on the stock market.
Today, he knows that the profit in shares is not necessarily the result of buying cheaply, but above all of avoiding mistakes and recognizing in good time when markets are ready to let air out. After all, in addition to basic fundamental analysis, investing in stocks is above all a phenomenon of global liquidity and this must be monitored regularly.
Commented by André Will-Laudien
Commented by André Will-Laudien on February 27th, 2024 | 07:00 CET
Timing is half the battle! Watch out for defense stocks: Renk, Rheinmetall, Hensoldt, and dynaCERT in focus!
Despite a red-green government, defense stocks are in demand again in Germany. After years of pacifism, Berlin's traffic light government is now firing up arms investments everywhere with conviction. The aim is to make the war in Ukraine a success for Europe by supplying weapons - an interesting experiment and an entirely new direction in the German political spectrum. The underfunding of the German Bundeswehr has been rightly recognized, and now an additional EUR 100 billion is to be allocated under the Basic Law. The stock market picks up on this trend and values the sought-after armaments higher and higher, and international exports are now more legitimized than ever. That is how quickly times change. This brings fantasy to the share price and a windfall for resourceful investors. Where do further opportunities lie?
Read
Commented by André Will-Laudien on February 23rd, 2024 | 07:00 CET
Will GreenTech soon be back in vogue? Nel ASA, Klimat X, Nordex, and Plug Power are under analyst scrutiny!
Despite new record highs in global stock markets, the GreenTech sector has yet to show any gains. The hydrogen sector, in particular, which was hyped in 2020/21, has been struggling for the past three years. With share price losses of 70 to 90%, investors are hopeful that a bottom could be reached in the foreseeable future. We analyze whether this could already be the case and present an alternative in the form of Klimat X. Business is running smoothly here, and the CO2 savings are even certified.
Read
Commented by André Will-Laudien on February 20th, 2024 | 07:30 CET
Takeover fever in the biotech sector! Will MorphoSys now be followed by Defence Therapeutics, Evotec and Bayer?
It has happened: Novartis is bidding for MorphoSys. Once again, a long-lasting and persistent rumour mill eventually confirms itself. Those who remained loyal to MorphoSys despite heavy selling last fall have now made a profit of over 300%. If we turn the analytical magnifying glass on the sector, we can see that the speculative biotech stock market segment has started to move again since the challenging year 2023. Hopes of falling interest rates in the near future, along with several other M&A hopes, have led to steady inflows into listed bio-ETFs, resulting in fund managers having recently adjusted their weightings upwards. We analyze which stocks are currently making the loudest noise.
Read
Commented by André Will-Laudien on February 16th, 2024 | 07:00 CET
MorphoSys and Cardiol Therapeutics in upward mode, while Bayer and Pfizer are in slow mode
The biotech sector has made a very differentiated start to the new year. While the old favorites are barely moving, the second-line stocks MorphoSys and Cardiol Therapeutics are making a real splash. At Bayer, the bad news just won't go away, and despite a successful major takeover, Pfizer has not yet found its forward gear. After a rally of almost 15% in December, the Nasdaq Biotechnology Index (NBI) has taken a pause in the current year. Now, everyone is waiting for the first interest rate cut by central banks. Inflation is already falling, and the negative economic data for the Eurozone is increasing. The ECB would normally be in demand. What should investors urgently keep an eye on?
Read
Commented by André Will-Laudien on February 13th, 2024 | 07:00 CET
Bear market in Hydrogen versus Bull market in Artificial Intelligence - Nel ASA, First Hydrogen, Nvidia and ARM Holdings
The stock market is relentless at the moment. While Nvidia has gained almost 50% in just 5 weeks, the stock market darlings Nel ASA and Plug Power continue to lose value. Small recovery attempts have been consistently sold off recently. No stone is being left unturned in this segment, and investors are eagerly awaiting the upcoming 2023 annual figures. Is there hope, or should we continue to write off hydrogen? On the other hand, some companies are making significant progress with a different business model, setting new records. So what to do? A brief update for active investors.
Read
Commented by André Will-Laudien on February 1st, 2024 | 07:45 CET
Combustion engine versus battery! BYD, Altech Advanced Materials, Mercedes and VW in focus
The year 2024 is going like clockwork for the high-tech sector so far. Anything smelling of "Artificial Intelligence" is being valued significantly higher on the stock market with relatively little scrutiny. In the DAX 40 Index, this has notably affected Siemens and SAP and the topic of armaments, which in turn catapulted Airbus and Rheinmetall into new realms. Things are even more dynamic on the Nasdaq, where Microsoft and Nvidia, in particular, are causing a sensation. However, e-mobility, particularly favoured by the Berlin traffic light coalition, is stumbling due to the abolition of the environmental bonus in December 2023. Customers are again opting for domestic combustion engines and Chinese e-imports. We analyze the current opportunities for investors.
Read
Commented by André Will-Laudien on January 30th, 2024 | 07:00 CET
Hydrogen Rally 3.0 - Is it starting now? Nel ASA and Plug Power with technical rebound opportunity, dynaCERT on the verge of certification
Is there now a possibility of a technical rebound in the hydrogen sector? This is a legitimate question for keen observers, as popular hydrogen stocks have remained on the sidelines since the beginning of the year. However, there have been signs of a noticeable stabilization in the H2 standard stocks in recent days. The second-line stocks are also attractive, as the focus is on special applications that use hydrogen to optimize fossil combustion processes. Whether the sector as a whole will experience a wave of investment in 2024 nevertheless remains an exciting question. Where are the opportunities for investors?
Read
Commented by André Will-Laudien on January 29th, 2024 | 07:00 CET
Demo against the right, overtake the left with these stocks! PayPal, Saturn Oil + Gas, Evotec and Bayer
Millions of people are on the streets, demonstrating for democracy. However, democracy also means pluralism, tolerance and fair discourse. It remains to be seen whether the politicians currently in power will eventually embrace these principles. The stock market is also a mass phenomenon, with many things developing in the same direction without much reflection. The herd instinct has both good and bad sides; on the capital markets, it often leads to irrational hype movements, as seen recently in the artificial intelligence sector. This technology is not an economic panacea either, as the elimination of jobs through the use of learning machines leads to less growth at the end of the day. As in all things, we need to use our heads, especially when it comes to the white knights of our future. Where are the opportunities for investors?
Read
Commented by André Will-Laudien on January 23rd, 2024 | 06:30 CET
Hydrogen sell-off: Invest now in high-tech blockbusters! Nel ASA, Defense Metals, AMD, Rheinmetall
Two important trends are emerging after 3 trading weeks on the stock market in 2024. The hydrogen sector is experiencing the long-awaited sell-off, while AI-related high-tech stocks are making new highs every day. Last week, the NASDAQ 100 Index reached a new all-time high of 17,340 points. Stocks such as Microsoft, Nvidia, Supermicro and AMD are moving upward daily with massive turnover. As chips also require a lot of strategic metals, the rare earth region of Wicheeda in Canada has also attracted media attention. As a result, the explorer Defense Metals has seen a significant increase in stock market turnover. No surprise: industrialized countries are looking for safe countries of origin for indispensable metals. Where are the opportunities for investors?
Read
Commented by André Will-Laudien on January 19th, 2024 | 07:45 CET
Total sell-off in hydrogen! Nel ASA, Manuka Resources, Plug Power - Find the 300% pearl now
The topic of hydrogen has been put on the back burner for the time being. Although the COP28 conference in Dubai showed a broad consensus on reducing greenhouse gases and avoiding fossil fuels, the OPEC countries, in particular, insist on their traditional right to continue tapping into the abundant oil wells. The observers conclude that everything remains the same; each does what it does best. The transformative idea of saving the world is collectively present, but if it can be solved with nuclear energy, then nuclear reactors will be built. This also highlights how the green-dominated traffic light policy on environmental issues is perceived internationally: Teachings from Germany are only smiled at. The topic of hydrogen was politically launched in Europe and has been traded on the stock exchange as a "world energy savior" since 2019; now, investors are sitting on a 90% loss. Is there still hope?
Read